Resistance pattern among contemporary Gram positive clinical isolates and in vitro activity of novel antibiotic, Levonadifloxacin (WCK 771)
Main Authors: | V. Kongre, S. Bhagwat, R.S. Bharadwaj |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | International Journal of Infectious Diseases |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971220308304 |
Similar Items
-
Resistance pattern among contemporary gram-negative clinical isolates and in vitro activity of novel antibiotic, WCK5222 (cefepime-zidebactam)
by: V. Kongre, et al.
Published: (2020-12-01) -
In Vitro activity of a Novel Benzoquinolizine Antibiotic, Levonadifloxacin (WCK 771) against Blood Stream Gram-Positive Isolates from a Tertiary Care Hospital
by: Dhruv Mamtora, et al.
Published: (2020-11-01) -
Levonadifloxacin: A Novel Approved Drug Exhibiting Potent In vitro Activity against Gram Positive Bacterial Isolates from Patients Admitted in Intensive Care Units
by: Tasneem Siddiqui, et al.
Published: (2021-07-01) -
Levonadifloxacin, a Novel Broad-Spectrum Anti-MRSA Benzoquinolizine Quinolone Agent: Review of Current Evidence
by: Bhagwat SS, et al.
Published: (2019-12-01) -
Electrocardiographic Effects of a Supratherapeutic Dose of WCK 2349, a Benzoquinolizine Fluoroquinolone
by: Jay W. Mason, et al.
Published: (2019-01-01)